Does PIMAVANSERIN Cause Cerebral atrophy? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Cerebral atrophy have been filed in association with PIMAVANSERIN (pimavanserin). This represents 0.0% of all adverse event reports for PIMAVANSERIN.
7
Reports of Cerebral atrophy with PIMAVANSERIN
0.0%
of all PIMAVANSERIN reports
2
Deaths
4
Hospitalizations
How Dangerous Is Cerebral atrophy From PIMAVANSERIN?
Of the 7 reports, 2 (28.6%) resulted in death, 4 (57.1%) required hospitalization.
Is Cerebral atrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PIMAVANSERIN. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does PIMAVANSERIN Cause?
Hallucination (10,839)
Death (9,352)
Drug ineffective (5,545)
Product dose omission issue (3,808)
Confusional state (3,779)
Fall (3,366)
Delusion (2,421)
Hallucination, visual (1,954)
Gait disturbance (1,923)
Parkinson's disease (1,918)
What Other Drugs Cause Cerebral atrophy?
FINGOLIMOD (87)
VALPROIC ACID (84)
PHENYTOIN (58)
METHOTREXATE (55)
LEVETIRACETAM (54)
CYCLOPHOSPHAMIDE (52)
OLANZAPINE (52)
CARBIDOPA\LEVODOPA (50)
VALPROATE (50)
OCRELIZUMAB (48)
Which PIMAVANSERIN Alternatives Have Lower Cerebral atrophy Risk?
PIMAVANSERIN vs PIMECROLIMUS
PIMAVANSERIN vs PIMOZIDE
PIMAVANSERIN vs PINAVERIUM
PIMAVANSERIN vs PINDOLOL
PIMAVANSERIN vs PIOGLITAZONE